Leishmaniasis treatment--a challenge that remains: a review. Parasitol Res 103: 1-10b.Santos DO, Countinho CER, Madeira MF. Leishmaniasis treatment-a challenge that remains: a review. Parasitol Res 2008;103:1-10.SANTOS, D. O. et al. Leishmaniasis treatment - a challenge that remains: ...
As most patients with PKDL (post-kala-azar dermal leishmaniasis) are asymptomatic, it is important that shorter regimens are developed, which will encourage patients to opt for complete treatment. Pharmaceutical industry and "not for profit' organizations should be encouraged to enhance the efforts...
Leishmaniasis is a disease transmitted by the bite of an infected sand fly. See pictures and learn about treatment, symptoms, diagnosis, types, prevention, risk factors, and prognosis.
Faced with this therapeutic challenge, we tested the effectiveness of photodynamic therapy (PDT) in the treatment of cutaneous leishmaniasis in terms of the number of treatments necessary to obtain eradication of amastigotes from the lesions, reduction of lesion size, cosmetic results, and adverse eff...
Treatment with pentavalent antimonials requires daily injections for 28 days, is not well tolerated and leads to initial clinical cure in only 66% of the co-infected cases. Free ABD has to be given, intravenously, for just as long, has significant toxicity and leads to initial clinical cure ...
REVIEW Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? François Chappuis*‡, Shyam Sundar§, Asrat Hailu||, Hashim Ghalib¶, Suman Rijal#, Rosanna W. Peeling¶, Jorge Alvar** and Marleen Boelaert‡‡ Abstract | Visceral leishmaniasis (VL) is a ...
Treatment for leishmaniasis depends on the specific form and severity of the disease. However, therapeutic options are often limited, and drug resistance poses a growing challenge in disease management. With the exception of Australia, the Pacific Islands, and Antarctica, the parasites have been iden...
Sundar S, Rai M (2005) Treatment of visceral leishmaniasis. Expert Opin Pharmacother 16:2821–2829ShyamSundar, MadhukarRai. (2005) Treatment of visceral leishmaniasis. Expert Opinion on Pharmacotherapy 6 :10.1517/eop.2005.6.issue-16, 2821-2829 /...
Treatment of recurrent cutaneous leishmaniasis. Int J Dermatol 1995; 34: 129-133.Momeni AZ, Aminjavaheri M. Treatment of recurrent cutane- ous leishmaniasis. Int J Dermatol 1995;34:129-33.Momeni, A.Z.; Aminjavaheri, M. Treatment of recurrent cutaneous leishmaniasis. Int. J. Dermatol. ...
Treatment of cutaneous leishmaniasis by topical 25% podophyllin solution (single, blinded, therapeutic, controlled study)Cutaneous leishmaniasisPodophyllinTreatmentThere are many therapies that had been used to treat cutaneous leishmaniasis (CL). To evaluate the effectiveness of topical 25% podophyllin...